Csenge Advisory Group Pfizer Inc Transaction History

Csenge Advisory Group

$1.97 Billion
Q3 2024

A detailed history of Csenge Advisory Group transactions in Pfizer Inc stock. As of the latest transaction made, Csenge Advisory Group holds 45,573 shares of PFE stock, worth $1.22 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares

45,573

Previous 46,900 2.83%

Holding current value

$1.22 Million

Previous $1.31 Million 0.46%

% of portfolio

0.07%

Previous 0.08%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$27.7 - $31.39 $36,757 - $41,654	-1,327 Reduced 2.83%	45,573 $1.32 Million
Q2 2024 Jul 10, 2024	BUY	$25.26 - $29.6 $32,964 - $38,628	1,305 Added 2.86%	46,900 $1.31 Million
Q1 2024 May 03, 2024	SELL	$25.89 - $29.73 $87,249 - $100,190	-3,370 Reduced 6.88%	45,595 $1.27 Million
Q4 2023 Feb 13, 2024	SELL	$26.13 - $33.94 $296,836 - $385,558	-11,360 Reduced 18.83%	48,965 $1.41 Million
Q3 2023 Nov 01, 2023	BUY	$32.09 - $37.51 $135,034 - $157,842	4,208 Added 7.5%	60,325 $2 Million
Q2 2023 Jul 20, 2023	SELL	$36.12 - $41.79 $43,199 - $49,980	-1,196 Reduced 2.09%	56,117 $2.06 Million
Q1 2023 May 01, 2023	SELL	$39.39 - $51.28 $3,072 - $3,999	-78 Reduced 0.14%	57,313 $2.34 Million
Q4 2022 Feb 10, 2023	BUY	$41.75 - $54.5 $7,431 - $9,701	178 Added 0.31%	57,391 $2.94 Million
Q3 2022 Oct 04, 2022	SELL	$43.76 - $53.42 $144,014 - $175,805	-3,291 Reduced 5.44%	57,213 $2.5 Million
Q2 2022 Jul 27, 2022	BUY	$46.53 - $55.17 $325,477 - $385,914	6,995 Added 13.07%	60,504 $3.17 Million
Q1 2022 May 09, 2022	BUY	$45.75 - $56.69 $177,327 - $219,730	3,876 Added 7.81%	53,509 $2.77 Million
Q4 2021 Feb 10, 2022	BUY	$41.32 - $61.25 $266,514 - $395,062	6,450 Added 14.94%	49,633 $1.96 Million
Q3 2021 Oct 20, 2021	SELL	$39.25 - $50.42 $253,162 - $325,209	-6,450 Reduced 13.0%	43,183 $1.85 Million
Q2 2021 Jul 21, 2021	BUY	$35.91 - $40.68 $737,196 - $835,119	20,529 Added 70.54%	49,633 $1.96 Million
Q1 2021 Apr 28, 2021	SELL	$33.49 - $37.77 $275,053 - $310,205	-8,213 Reduced 22.01%	29,104 $1.07 Million
Q4 2020 Jan 26, 2021	SELL	$33.47 - $42.56 $20,115 - $25,578	-601 Reduced 1.58%	37,317 $1.37 Million
Q3 2020 Nov 09, 2020	BUY	$31.75 - $37.25 $36,957 - $43,359	1,164 Added 3.17%	37,918 $1.37 Million
Q2 2020 Jul 17, 2020	BUY	$30.12 - $36.54 $462,251 - $560,779	15,347 Added 71.69%	36,754 $1.2 Million
Q1 2020 Apr 21, 2020	BUY	$27.03 - $38.62 $168,559 - $240,834	6,236 Added 41.1%	21,407 $699,000
Q4 2019 Feb 05, 2020	BUY	$32.92 - $37.36 $26,763 - $30,373	813 Added 5.66%	15,171 $594,000
Q3 2019 Nov 14, 2019	SELL	$32.49 - $42.13 $253,162 - $328,276	-7,792 Reduced 35.18%	14,358 $516,000
Q2 2019 Jul 30, 2019	BUY	$36.98 - $41.52 $119,223 - $133,860	3,224 Added 17.03%	22,150 $959,000
Q1 2019 May 07, 2019	SELL	$37.5 - $41.2 $375,712 - $412,782	-10,019 Reduced 34.61%	18,926 $803,000
Q4 2018 Feb 07, 2019	BUY	$38.47 - $43.86 $100,214 - $114,255	2,605 Added 9.89%	28,945 $1.26 Million
Q3 2018 Nov 19, 2018	BUY	$34.47 - $41.81 $423,360 - $513,510	12,282 Added 87.37%	26,340 $1.13 Million
Q2 2018 Aug 10, 2018	SELL	$32.98 - $35.16 $35,651 - $38,007	-1,081 Reduced 7.14%	14,058 $510,000
Q1 2018 May 10, 2018	BUY	$31.91 - $37.02 $106,483 - $123,535	3,337 Added 28.27%	15,139 $537,000
Q4 2017 Feb 15, 2018	BUY	$33.26 - $35.29 $392,534 - $416,492	11,802	11,802 $427,000

Others Institutions Holding PFE

# of Institutions

3,260

Shares Held

3.61B

Call Options Held

77.2M

Put Options Held

122M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $150B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Csenge Advisory Group, based on Form 13F filings with the SEC.

News

Stay updated on Csenge Advisory Group with notifications on news.

Account

Csenge Advisory Group Pfizer Inc Transaction History